[Bisphosphonates for myeloma patients]

[Bisphosphonates for myeloma patients] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Bisphosphonates for myeloma patients] Abstract Text:

Akiyoshi Miwa,Akiyoshi Miwa,

Several species of bisphosphonate (BP) have been widely used as one of the standardized supportive therapy for myeloma patients, because of the efficacy evidenced by lots of prospective randomised trials showing the decreased incidence of the skeletal-related events. In addition, BPs have lots of beneficial effects on myeloma patients, including the enhancement of lymphocyte subset, and anti-myeloma effects possibly by 'indirect' effects on myeloma cells via apoptosis-inducing effects on osteoclasts, as well as 'direct' apoptosis -inducing effects on myeloma cells. On the contrary, BPs have been shown to have adverse events, including transient flu -like syndrome accompanied by fever and transient inflammatory reactions, and unexpected severe tissue damage, named 'osteonecrosis of the jaw (ONJ)'. Once ONJ developed in myeloma patients, myeloma therapies could be influenced drastically at times, because ONJ site could become infection focus and necessitate cessation of cytotoxic therapy in order to support tissue repair in situ. Prevention of ONJ might be feasible through oral hygiene, because ONJ develops almost always in patients with long-history of dental diseases.

[Bisphosphonates for myeloma patients] Publishing Authors By Initials

A Miwa,A Miwa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Bisphosphonates for myeloma patients] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Nippon rinsho. Japanese journal of clinical medici

VOLUME: 65

Page Numbers: 2315-37

Journal Abbreviation: Nippon Rinsho

ISSN: 0047-1852

DAY: 11

MONTH: Dec

YEAR: 2007

[Bisphosphonates for myeloma patients] Information

Number of References:

LANGUAGE: jpn

NlmUniqueID: 420546

[Bisphosphonates for myeloma patients] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Bisphosphonates for myeloma patients] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Bisphosphonates for myeloma patients]

AFFILIATION: Department of Hematology, International Medical Center of Japan.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nippon Rinsho

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bisphosphonates for myeloma patients Related Publications

• A novel method for purification of poly(ADP-ribose).
• A rapid and inexpensive method to screen for common foods that reduce the action of acrylamide, a harmful substance in food.
• Acrylamide-Responsive Genes in the Nematode Caenorhabditis elegans.
• Activation of a polyvalent cation-sensing receptor decreases magnesium transport via claudin-16.
• Age-dependent telomere-shortening is repressed by phosphorylated alpha-tocopherol together with cellular longevity and intracellular oxidative-stress reduction in human brain microvascular endotheliocytes.
• Antitumor and anti-invasive effects of diverse new macrocyclic lactones, alkylolides and alkenylolides, and their enhancement by hyperthermia.
• Assessment of the centrosome amplification by quantification of gamma-tubulin in Western blotting.
• Characterization of noradrenaline-induced increases in intracellular Ca2+ levels in Chinese hamster ovary cells stably expressing human alpha1A-adrenoceptor.
• Chemokines in systemic lupus erythematosus involving the central nervous system.
• Claudin-16 is directly phosphorylated by protein kinase a independently of a vasodilator-stimulated phosphoprotein-mediated pathway.
• Difference in mechanism between glyceraldehyde- and glucose-induced insulin secretion from isolated rat pancreatic islets.
• Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects.
• Expression of Hepatic UDP-Glucuronosyltransferase 1A1 and 1A6 Correlated with Increased Expression of the Nuclear Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor {alpha} in Male Rats Fed a High-Fat and High-Sucrose Diet.
• Fluorescence quenching as an indicator for the exposure of tryptophyl residues in Streptomyces subtilisin inhibitor.
• Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection.
• Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s).
• Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
• Phase I study of paclitaxel plus irinotecan combination therapy for patients with refractory and advanced gastric cancer.
• Stereotyped behavior or punding in Parkinson's disease.
• Studies on pyruvate kinase (PK) deficiency. II. Electrophoretic, kinetic and immunological studies on pyruvate kinase of erythrocytes and other tissues.
• Thallium Transport and the Evaluation of Olfactory Nerve Connectivity between the Nasal Cavity and Olfactory Bulb.
• [A case of adult neuroblastoma arising in the retroperitoneum following a poorly aggressive course]
• [Advances in therapeutic strategies for multiple myeloma.]
• [Bisphosphonates for myeloma patients]
• [How to diagnose a patient precisely as a myeloma patient?--Lots of problems during diagnostic process]
• [Morphology and growth mechanism of myeloma cells]
• [Relations of the diencephalon gland, the supra-renal capsule and the thyroid gland.]
• [Study on the mechanism of inhibition of tumor cell motility by ascorbic acid derivatives]
• [Water-wettability of a contact lens. II.]
• [Water-wettability of a contact lens]